Peggy Nicolacopoulos

Peggy Nicolacopoulos is an experienced professional in the pharmaceutical and healthcare industries, currently serving as Executive Director and GU & GI Tumor Lead at Bristol Myers Squibb since October 2020. Prior to this role, Peggy held various senior positions at Bristol Myers Squibb, including Head of Strategy and Operations and Senior Director of Strategy and Operations in US Oncology. During tenure at Novo Nordisk from April 2016 to October 2020, Peggy successfully launched a next-generation Hemophilia A brand and ensured competitiveness for pipeline assets. Additional experience includes leadership roles at Ferring Pharmaceuticals, ChemPoint, and Pfizer Inc., where Peggy was responsible for marketing strategies and product management across multiple therapeutic areas. Peggy holds an MSc in International Management/Marketing from King's College London and two degrees from the University of Patras: a BSc in Chemistry and an MSc in Medicinal Chemistry with a focus on Drug Design and Development.